Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Glucagon-like Peptide-1”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Looking for participantsNCT07242534
What this trial is testing

Effect of Semaglutide on Embryo Quality in Overweight and Obese Patients Undergoing In Vitro Fertilization.

Who this might be right for
InfertilityObesity
Fundacion Dexeus 62
Not applicableStudy completedNCT07269821
What this trial is testing

Evaluation of a Nutritional Intervention With Dietary Supplements in People Who Have Recently Lost Weight: Effects on Body Composition, Emotional Health, and Gut Microbiota

Who this might be right for
GLP-1Weight Loss TrajectoryEmotional Disorder+1 more
University of Alicante 70
Post-approval studies (Phase 4)Looking for participantsNCT07588438
What this trial is testing

Efficacy, Safety, and Tolerability of Tirzepatide in Real-World Conditions in Paraguay.

Who this might be right for
ObesityDiabetes Mellitus, Type 2
Las Rías Medical Center 160
Not applicableActive Not RecruitingNCT06484114
What this trial is testing

Evaluation of the Safety and Efficacy of Revita® DMR on Body Weight Maintenance in Subjects With Obesity Who Have Achieved at Least 15% Weight Loss on Tirzepatide

Who this might be right for
ObesityWeight Change TrajectoryWeight Change, Body
Fractyl Health Inc. 315
Large-scale testing (Phase 3)Study completedNCT04255433
What this trial is testing

Tirzepatide (LY3298176) Compared With Dulaglutide on Major Cardiovascular Events in Participants With Type 2 Diabetes

Who this might be right for
Type 2 Diabetes Mellitus
Eli Lilly and Company 13,299
Large-scale testing (Phase 3)Looking for participantsNCT07428746
What this trial is testing

Investigating the Impact of GLP-1 RA Therapy on Osteosarcopenia in Older Female Adults With Diabetes

Who this might be right for
Diabetes Mellitus, Type 2
Emory University 20
Not applicableStudy completedNCT00256256
What this trial is testing

The Effect of GLP-1 on Glucose Uptake in the Brain and Heart in Healthy Men

Who this might be right for
Type 2 DiabetesStrokeMyocardial Infarction
University of Aarhus 10
Not applicableStudy completedNCT07744360
What this trial is testing

A Pilot Study Evaluating the Impact of a Prebiotic Soda on Gastrointestinal Symptoms in Users of GLP-1 Agonists

Who this might be right for
GI Symptoms
Olipop, PBC 80
Not applicableLooking for participantsNCT06725693
What this trial is testing

Glucagon-like Peptide-1 Receptor PET/CT in GLP-1R Related Disease

Who this might be right for
GLP1-R-related DiseaseTumorInsulinoma+1 more
Tianjin Medical University 500
Early research (Phase 1)Active Not RecruitingNCT07223216
What this trial is testing

Study of BMF-650 in Otherwise Healthy Overweight or Obese Adult Participants

Who this might be right for
Obesity
Biomea Fusion Inc. 80
Early research (Phase 1)Study completedNCT01972893
What this trial is testing

A Clinical Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of ZYD1, Following Subcutaneous Administration in Healthy Volunteers

Who this might be right for
Type 2 Diabetes Mellitus
Zydus Lifesciences Limited 56
Testing effectiveness (Phase 2)Study completedNCT04687514
What this trial is testing

Effects of Glucagon-Like Peptide-1 Analogs on Sexuality

Who this might be right for
Sexual Functioning
University Hospital, Basel, Switzerland 26
Large-scale testing (Phase 3)Study completedNCT01607450
What this trial is testing

Modulation of Human Myocardial Metabolism by GLP-1 Dose Response

Who this might be right for
Type 2 Diabetes MellitusHealthy
Indiana University 33
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07217743
What this trial is testing

Assess Impact of Poly-L-lactic Acid on GLP1 Subjects

Who this might be right for
Laxity; Skin
Goldman, Butterwick, Fitzpatrick and Groff 20
Large-scale testing (Phase 3)Ended earlyNCT03419624
What this trial is testing

The Potential of Dapagliflozin Plus Exenatide in Obese Insulin-resistant Patients

Who this might be right for
ObesityDiabetes Mellitus, Type 2
Universitätsklinikum Hamburg-Eppendorf 13
Not applicableStudy completedNCT02497859
What this trial is testing

Breakfast Intake and Satiety Hormones

Who this might be right for
Obesity
Texas Tech University 20
Testing effectiveness (Phase 2)Looking for participantsNCT07685808
What this trial is testing

Study of Olatorepatide in Adult Participants Living With Overweight or Obesity Without Diabetes

Who this might be right for
Overweight or Obesity
Regeneron Pharmaceuticals 360
Testing effectiveness (Phase 2)Study completedNCT02838589
What this trial is testing

The Effect of GLP-1 Receptor Agonist on Cerebral Blood Flow Velocity in Non-stroke Volunteers

Who this might be right for
Stroke
Christina Kruuse 30
Not applicableStudy completedNCT07368855
What this trial is testing

GLP-1 Medicines and Mental Health Changes

Who this might be right for
ObesityDepressionGLP-1
University of California, San Diego 90
Not applicableNot Yet RecruitingNCT07567378
What this trial is testing

CARTIZ Registry: Cartilage, Arthropathy and Imaging Under Tirzepatide in Zone-stratified Cohorts - A Four-Institute Mexican Observational Registry

Who this might be right for
Psoriatic ArthritisOsteoarthitisKnee+12 more
JULIO GRANADOS MONTIEL 30
Next Page